RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
SAGLIO G
Collezione AOU San Luigi di Orbassano
Items : 110
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia. in Scientific reports / Sci Rep. 2024 Jul 2;14(1):15089. doi: 10.1038/s41598-024-65404-7.
2024
AOU San Luigi di Orbassano
Poggio P; Rocca S; Fusella F; Ferretti R; Ala U; D'Anna F; Giugliano E; Panuzzo C; Fontana D; Palumbo V; Carrà G; Taverna D; Gambacorti-Passerini C; Saglio G; Fava C; Piazza R; Morotti A; Orso F; Brancaccio M;
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.
2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Baccarani M; Cavo M; Saglio G; Pane F; Foà R; Simula MP; Albano F; Soverini S; Porretto F; Sorà F; Cavazzini F; Trabacchi E; Cedrone M; Bocchia M; Tiribelli M; Martino B; Rege-Cambrin G; Salvucci M; Stagno F; D'Adda M; Intermesoli T; Levato L; Breccia M; Castagnetti F; Gugliotta G; Rosti G;
Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms. in Journal of clinical medicine / J Clin Med. 2022 Feb 25;11(5):1267. doi: 10.3390/jcm11051267.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Saglio G; Lo Iacono M; Giugliano E; Marini S; Armenio M; Fava C; Frolli A; Signorino E; Itri F; Petiti J; Cilloni D;
Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start? in Cancers / Cancers (Basel). 2021 Oct 30;13(21):5470. doi: 10.3390/cancers13215470.
2021
AOU San Luigi di Orbassano
Bochicchio MT; Petiti J; Berchialla P; Izzo B; Giugliano E; Ottaviani E; Errichiello S; Rege-Cambrin G; Venturi C; Luciano L; Daraio F; Calistri D; Rosti G; Saglio G; Martinelli G; Pane F; Cilloni D; Gottardi EM; Fava C;
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid Leukemia. in Diseases (Basel, Switzerland) / Diseases. 2021 May 5;9(2):35. doi: 10.3390/diseases9020035.
2021
AOU San Luigi di Orbassano
Fava C; Bernardi S; Gottardi EM; Lorenzatti R; Galeotti L; Ceccherini F; Cordoni F; Daraio F; Giugliano E; Jovanovski A; Petiti J; Varotto M; Barberio D; Rege-Cambrin G; Berchialla P; Sciannameo V; Malagola M; Saglio G; Russo D;
JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy. in Journal of clinical medicine / J Clin Med. 2021 Aug 23;10(16):3752. doi: 10.3390/jcm10163752.
2021
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano
Saglio G; Coco P; Paley C; Zuurman M; Ascierto PA; Turrini M; Palazzolo R; Schettino G; Bocchia M; Morelli M; Tedeschi A; Festuccia MB; Monforte AD; Capochiani E; Selleri C; Simonetti F; Saracino A; Rapezzi D; Badagliacca MR; Falasca K; Molteni A; Mortara A; D'Alessio A; Vannucchi AM;
Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase. in Frontiers in oncology / Front Oncol. 2021 Mar 16;11:642005. doi: 10.3389/fonc.2021.642005. eCollection 2021.
2021
AOU San Luigi di Orbassano
Breccia M; Saglio G; Rosti G; Castagnetti F; Pane F;
Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR. in Cancers / Cancers (Basel). 2020 Nov 6;12(11):3287. doi: 10.3390/cancers12113287.
2020
AOU San Luigi di Orbassano
Cilloni D; Saglio G; Gottardi EM; Giugliano E; Petiti J; Jovanovski A; Fava C;
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts. in Journal of clinical medicine / J Clin Med. 2020 May 13;9(5):1457. doi: 10.3390/jcm9051457.
2020
AOU San Luigi di Orbassano
Gottardi EM; Saglio G; Rege-Cambrin G; Divona M; Izzo B; Quarantelli F; Rapanotti MC; Fantino C; Pironi L; Dragani M; Lo Iacono M; Petiti J; Cilloni D; Fava C;
Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia. in Journal of clinical medicine / J Clin Med. 2020 Jan 19;9(1):271. doi: 10.3390/jcm9010271.
2020
AOU San Luigi di Orbassano
Lo Iacono M; Fava C; Saglio G; Lunghi M; De Gobbi M; Dragani M; Andreani G; Franceschi V; Croce E; Rosso V; Petiti J; Cilloni D;
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.
2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Cavo M; Baccarani M; Rosti G; Tenti E; Laginestra MA; Pileri SA; Percesepe A; Mignone F; Vigneri P; Saglio G; Pane F; Errichiello S; Serra A; Stella S; Calistri E; Annunziata M; Bocchia M; Musolino C; Attolico I; Coluzzi S; Capodanno I; Girasoli M; Sancetta R; Salvucci M; Binotto G; Abruzzese E; D'Adda M; di Bona E; di Raimondo F; et alii...
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. in Leukemia / Leukemia. 2020 Aug;34(8):2260-2261. doi: 10.1038/s41375-020-0904-z. Epub 2020 Jun 18.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AO Cuneo
Pregno P; Rege-Cambrin G; Rosti G; Stagno F; Tiribelli M; Foà R; Saglio G; Luciano L; Iurlo A; Latagliata R; Gugliotta G; Galimberti S; Gozzini A; Fava C; Bonifacio M; Castagnetti F; Bocchia M; Abruzzese E; Breccia M;
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes. in Annals of hematology / Ann Hematol. 2020 Apr;99(4):891-893. doi: 10.1007/s00277-020-03913-x. Epub 2020 Feb 4.
2020
AOU San Luigi di Orbassano
Fava C; Saglio G; Lo Iacono M; Croce E; Andreani G; Dragani M; Petiti J; Rosso V; Cilloni D;
Nilotinib in the treatment of chronic myeloid leukemia. in Future oncology (London, England) / Future Oncol. 2019 Mar;15(9):953-965. doi: 10.2217/fon-2018-0468. Epub 2018 Dec 14.
2019
AOU San Luigi di Orbassano
Sacha T; Saglio G;
First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Jul;59(7):1523-1538. doi: 10.1080/10428194.2017.1379074. Epub 2017 Oct 3.
2018
AOU San Luigi di Orbassano
Saglio G; Jabbour E;
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Iurlo A; Galimberti S; Abruzzese E; Annunziata M; Bonifacio M; Latagliata R; Pregno P; Ferrero D; Sorà F; Orlandi EM; Fava C; Cattaneo D; Bucelli C; Binotto G; Pungolino E; Tiribelli M; Gozzini A; Gugliotta G; Castagnetti F; Stagno F; Rege-Cambrin G; Martino B; Luciano L; Breccia M; Sica S; Bocchia M; Pane F; Saglio G; Rosti G; et alii...
Dasatinib dose management for the treatment of chronic myeloid leukemia. in Cancer / Cancer. 2018 Apr 15;124(8):1660-1672. doi: 10.1002/cncr.31232. Epub 2018 Jan 25.
2018
AOU San Luigi di Orbassano
Talpaz M; Saglio G; Atallah E; Rousselot P;
Myelodysplastic syndromes with hypocellular marrow: Clinical characteristics and evaluation of outcome in HemaSphere
2018
ASL Biella
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Alessandria
ASL Novara
Santini V; Gioia D; Masiera E; Poloni A; Ferrero D; Fragasso A; Finelli C; Salvi F; Gaidano G; Oliva EN; Catarini M; Cametti G; Bonferroni M; Danise P; Tassara R; Allione B; Cilloni D; Castelli A; Centurioni R; Ciravegna G; Visani G; Musto P; Balleari E; Biale L; Capelli D; Frairia C; Galimberti S; Giaccone L; Macchi S; et alii...
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia. in Haematologica / Haematologica. 2017 Sep;102(9):1530-1536. doi: 10.3324/haematol.2017.169532. Epub 2017 Jun 1.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Gugliotta G; Castagnetti F; Breccia M; Albano F; Iurlo A; Intermesoli T; Abruzzese E; Levato L; D'Adda M; Pregno P; Cavazzini F; Stagno F; Martino B; La Barba G; Sorà F; Tiribelli M; Bigazzi C; Binotto G; Bonifacio M; Caracciolo C; Soverini S; Foà R; Cavo M; Martinelli G; Pane F; Saglio G; Baccarani M; Rosti G;
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. in Oncotarget / Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A;
5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 18;10(1):18. doi: 10.1186/s13045-016-0382-y.
2017
AOU San Luigi di Orbassano
Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A;
Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening. in Tissue engineering. Part C, Methods / Tissue Eng Part C Methods. 2017 Feb;23(2):72-85. doi: 10.1089/ten.TEC.2016.0404. Epub 2017 Jan 13.
2017
AOU San Luigi di Orbassano
Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M;
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes. in British journal of haematology / Br J Haematol. 2017 Feb;176(3):491-495. doi: 10.1111/bjh.13968. Epub 2016 Feb 23.
2017
AOU San Luigi di Orbassano
Di Savino A; Gaidano V; Palmieri A; Crasto F; Volpengo A; Lorenzatti R; Scaravaglio P; Manello A; Nicoli P; Gottardi E; Saglio G; Cilloni D; De Gobbi M;
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios. in Annals of hematology / Ann Hematol. 2017 Aug;96(8):1303-1313. doi: 10.1007/s00277-017-3012-z. Epub 2017 May 22.
2017
AOU San Luigi di Orbassano
Saglio G; le Coutre P; Cortes J; Mayer J; Rowlings P; Mahon FX; Kroog G; Gooden K; Subar M; Shah NP;
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2017 Apr;79(4):767-773. doi: 10.1007/s00280-017-3271-3. Epub 2017 Mar 13
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Petrini M; Danesi R; Arrigoni E; Grassi S; Ciabatti E; Fontanelli G; Guerrini F; Cervetti G; D'Avolio A; Fava C; Baratè C; Di Paolo A; Polillo M; Laurino M; Domingo D; Galeotti L; Ceccherini F; Cornolti F; Saglio G; Galimberti S;
Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis. in BioMed research international / Biomed Res Int. 2017;2017:2408941. doi: 10.1155/2017/2408941. Epub 2017 May 2.
2017
AOU San Luigi di Orbassano
Pellegrino RM; Riondato F; Ferbo L; Boero M; Palmieri A; Osella L; Pollicino P; Miniscalco B; Saglio G; Roetto A;
Tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia: A retrospective analysis of 208 Italian patients in Haematologica
2017
AOU San Luigi di Orbassano
Fava C; Rege-Cambrin G; Dogliotti I; Berchialla P; Cerrano M; Rosti G; Castagnetti F; Gugliotta G; Martino B; Gambacorti-Passerini C; Abruzzese E; Orlandi E; Chiara E; Pregno P; Gozzini A; Avanzini P; Bergamaschi M; Crugnola M; Bocchia M; Galimberti S; Rapezzi D; Iurlo A; Cattaneo D; Latagliata R; Breccia M; Cedrone M; Santoro M; Annunziata M; Levato L; et alii...
The automated molecular technique “ultra” allows a sensitive and accurate BCR-ABL1 quantification in patients affected by chronic myeloid leukemia in Haematologica
2017
AOU San Luigi di Orbassano
Guerrini F; Izzo B; Gottardi E; Bochicchio MT; Morganti R; Grassi S; Barate C; Erricchiello S; Pedri R; Metelli MR; Lorenzatti R; Di Vita A; Domenichini C; Saglio G; Pane F; Petrini M; Martinelli G; Galimberti S;
Characterization of human mitochondrial ferritin promoter: identification of transcription factors and evidences of epigenetic control. in Scientific reports / Sci Rep. 2016 Sep 14;6:33432. doi: 10.1038/srep33432.
2016
AOU San Luigi di Orbassano
Guaraldo M; Santambrogio P; Rovelli E; Di Savino A; Saglio G; Cittaro D; Roetto A; Levi S;
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale. in Leukemia / Leukemia. 2016 Sep;30(9):1844-52. doi: 10.1038/leu.2016.90. Epub 2016 Apr 25.
2016
AOU San Luigi di Orbassano
Cross NC; White HE; Ernst T; Welden L; Dietz C; Saglio G; Mahon FX; Wong CC; Zheng D; Wong S; Wang SS; Akiki S; Albano F; Andrikovics H; Anwar J; Balatzenko G; Bendit I; Beveridge J; Boeckx N; Cerveira N; Cheng SM; Colomer D; Czurda S; Daraio F; Dulucq S; Eggen L; El Housni H; Gerrard G; Gniot M; et alii...
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients. in Haematologica / Haematologica. 2016 Oct;101(10):1200-1207. doi: 10.3324/haematol.2016.144949. Epub 2016 Jul 28.
2016
AOU San Luigi di Orbassano
Castagnetti F; Breccia M; Gugliotta G; Martino B; D'Adda M; Stagno F; Carella AM; Avanzini P; Tiribelli M; Trabacchi E; Visani G; Gobbi M; Salvucci M; Levato L; Binotto G; Capalbo SF; Bochicchio MT; Soverini S; Cavo M; Martinelli G; Alimena G; Pane F; Saglio G; Rosti G; Baccarani M;
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome. in Oncotarget / Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Iurlo A; Nobili A; Latagliata R; Bucelli C; Castagnetti F; Breccia M; Abruzzese E; Cattaneo D; Fava C; Ferrero D; Gozzini A; Bonifacio M; Tiribelli M; Pregno P; Stagno F; Vigneri P; Annunziata M; Cavazzini F; Binotto G; Mansueto G; Russo S; Falzetti F; Montefusco E; Gugliotta G; Storti S; D'Addosio AM; Scaffidi L; Cortesi L; Cedrone M; et alii...
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase. in BMC cancer / BMC Cancer. 2016 May 16;16:314. doi: 10.1186/s12885-016-2346-6.
2016
AOU San Luigi di Orbassano
Crivellaro S; Carrà G; Panuzzo C; Taulli R; Guerrasio A; Saglio G; Morotti A;
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity. in Cancer / Cancer. 2016 May 1;122(9):1398-407. doi: 10.1002/cncr.29933. Epub 2016 Mar 21.
2016
AOU San Luigi di Orbassano
Schiffer CA; Cortes JE; Hochhaus A; Saglio G; le Coutre P; Porkka K; Mustjoki S; Mohamed H; Shah NP;
Ponatinib for chronic myeloid leukaemia: future perspectives. in The Lancet. Oncology / Lancet Oncol. 2016 May;17(5):546-7. doi: 10.1016/S1470-2045(16)30064-X. Epub 2016 Apr 12.
2016
AOU San Luigi di Orbassano
Fava C; Saglio G;
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.
2016
AOU San Luigi di Orbassano
AOU Novara
Pane F; Martinelli G; Alimena G; Cavo M; Soverini S; Venturi C; Levato L; Musolino C; Pia Falcone A; Lunghi M; Tiribelli M; Cavazzini F; Bocchia M; D'Adda M; Luciano L; Stagno F; Albano F; Martino B; Abruzzese E; Rege-Cambrin G; Usala E; Carella AM; Gozzini A; Breccia M; Castagnetti F; Gugliotta G; Saglio G; Rosti G; Baccarani M; et alii...
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants. in BMC cancer / BMC Cancer. 2016 Aug 2;16:572. doi: 10.1186/s12885-016-2635-0.
2016
AOU San Luigi di Orbassano
Soverini S; De Benedittis C; Castagnetti F; Gugliotta G; Mancini M; Bavaro L; Machova Polakova K; Linhartova J; Iurlo A; Russo D; Pane F; Saglio G; Rosti G; Cavo M; Baccarani M; Martinelli G;
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse. in Scientific reports / Sci Rep. 2016 Aug 1;6:30725. doi: 10.1038/srep30725.
2016
AOU San Luigi di Orbassano
Pellegrino RM; Boda E; Montarolo F; Boero M; Mezzanotte M; Saglio G; Buffo A; Roetto A;
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100. doi: 10.1016/j.clml.2016.03.008. Epub 2016 A
2016
AOU San Luigi di Orbassano
Fava C; Rege-Cambrin G; Dogliotti I; Gottardi E; Berchialla P; Di Gioacchino B; Crasto F; Lorenzatti R; Volpengo A; Daraio F; Fantino C; Saglio G;
A comparative study of myocardial molecular phenotypes of two tfr2? null mice: role in ischemia/reperfusion. in BioFactors (Oxford, England) / Biofactors. 2015 Sep-Oct;41(5):360-71. doi: 10.1002/biof.1237. Epub 2015 Oct 13.
2015
AOU San Luigi di Orbassano
Boero M; Pagliaro P; Tullio F; Pellegrino RM; Palmieri A; Ferbo L; Saglio G; De Gobbi M; Penna C; Roetto A;
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia. in Haematologica / Haematologica. 2015 Sep;100(9):1146-50. doi: 10.3324/haematol.2015.129221. Epub 2015 Jun 25.
2015
AOU San Luigi di Orbassano
Gugliotta G; Castagnetti F; Breccia M; Levato L; D'Adda M; Stagno F; Tiribelli M; Salvucci M; Fava C; Martino B; Cedrone M; Bocchia M; Trabacchi E; Cavazzini F; Usala E; Russo Rossi A; Bochicchio MT; Soverini S; Alimena G; Cavo M; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G;
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. in Leukemia / Leukemia. 2015 Sep;29(9):1823-31. doi: 10.1038/leu.2015.152. Epub 2015 Jun 19.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Castagnetti F; Gugliotta G; Breccia M; Stagno F; Iurlo A; Albano F; Abruzzese E; Martino B; Levato L; Intermesoli T; Pregno P; Rossi G; Gherlinzoni F; Leoni P; Cavazzini F; Venturi C; Soverini S; Testoni N; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G; Baccarani M;
Milestones and monitoring. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2015 Jun;10(2):167-72. doi: 10.1007/s11899-015-0258-1.
2015
AOU San Luigi di Orbassano
Morotti A; Fava C; Saglio G;
Update on emerging treatments for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31
2015
AOU San Luigi di Orbassano
Fava C; Morotti A; Dogliotti I; Saglio G; Rege-Cambrin G;
Differences among young adults, adults and elderly chronic myeloid leukemia patients. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jan;26(1):185-192. doi: 10.1093/annonc/mdu490. Epub 2014 Oct 30.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Castagnetti F; Gugliotta G; Baccarani M; Breccia M; Specchia G; Levato L; Abruzzese E; Rossi G; Iurlo A; Martino B; Pregno P; Stagno F; Cuneo A; Bonifacio M; Gobbi M; Russo D; Gozzini A; Tiribelli M; de Vivo A; Alimena G; Cavo M; Martinelli G; Pane F; Saglio G; Rosti G;
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina. in Blood / Blood. 2015 Apr 30;125(18):2771-8. doi: 10.1182/blood-2014-09-601674. Epub 2015 Mar 12.
2015
AOU San Luigi di Orbassano
Wang J; Shen ZX; Saglio G; Jin J; Huang H; Hu Y; Du X; Li J; Meng F; Zhu H; Hu J; Wang J; Hou M; Hertle S; Menssen HD; Ortmann CE; Tribouley C; Yuan Y; Baccarani M; Huang X;
The choice of first-line chronic myelogenous leukemia treatment. in Annals of hematology / Ann Hematol. 2015 Apr;94 Suppl 2(Suppl 2):S123-31. doi: 10.1007/s00277-015-2321-3. Epub 2015 Mar 27.
2015
AOU San Luigi di Orbassano
Fava C; Rege-Cambrin G; Saglio G;
HAUSP compartmentalization in chronic myeloid leukemia. in European journal of haematology / Eur J Haematol. 2015 Apr;94(4):318-21. doi: 10.1111/ejh.12422. Epub 2014 Sep 3.
2015
AOU San Luigi di Orbassano
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G;
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia. in Oncoscience / Oncoscience. 2015 Nov 11;2(10):880-91. doi: 10.18632/oncoscience.260. eCollection 2015.
2015
AOU San Luigi di Orbassano
Panuzzo C; Volpe G; Cibrario Rocchietti E; Casnici C; Crotta K; Crivellaro S; Carrà G; Lorenzatti R; Peracino B; Torti D; Morotti A; Camacho-Leal MP; Defilippi P; Marelli O; Saglio G;
mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein. in Oncoscience / Oncoscience. 2015 Apr 6;2(4):382-94. doi: 10.18632/oncoscience.148. eCollection 2015.
2015
AOU San Luigi di Orbassano
Guglielmelli T; Giugliano E; Brunetto V; Rapa I; Cappia S; Giorcelli J; Rrodhe S; Papotti M; Saglio G;
BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation. in Cell cycle (Georgetown, Tex.) / Cell Cycle. 2015;14(7):973-9. doi: 10.1080/15384101.2015.1006970.
2015
AOU San Luigi di Orbassano
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Fava C; Guerrasio A; Pandolfi PP; Saglio G;
Comparison of droplet digital PCR and standard PCR in chronic myeloid leukemia patients in MR4 in Haematologica
2015
AOU San Luigi di Orbassano
Fava C; Gottardi E; Berchialla P; Rege-Cambrin G; Varotto M; Daraio F; Crasto F; Lorenzatti R; Volpengo A; Fantino C; Dani N; Barberio D; Dogliotti I; Saglio G;
2015
AOU San Luigi di Orbassano
Gugliotta G; Castagnetti F; Breccia M; Gozzini A; Stagno F; Rege-Cambrin G; Carella AM; Luciano L; Specchia G; Abruzzese E; Martino B; Usala E; Rossi G; Bocchia M; Cavazzini F; Tiribelli M; Venturi C; Soverini S; Alimena G; Cavo M; Pane F; Martinelli G; Saglio G; Rosti G; Baccarani M;
Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemia. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2014 Mar;14(3):287-99. doi: 10.1517/14712598.2014.867323. Epub 2014 Jan 3.
2014
AOU San Luigi di Orbassano
Morotti A; Panuzzo C; Fava C; Saglio G;
Plasma and intracellular imatinib concentrations in patients with chronic myeloid leukemia. in Therapeutic drug monitoring / Ther Drug Monit. 2014 Jun;36(3):410-2. doi: 10.1097/FTD.0000000000000013.
2014
AOU San Luigi di Orbassano
De Francia S; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G;
BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia. in PloS one / PLoS One. 2014 Oct 24;9(10):e110682. doi: 10.1371/journal.pone.0110682. eCollection 2014.
2014
AOU San Luigi di Orbassano
Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G; Morotti A;
Safety and tolerability of dasatinib in patients with chronic myeloid leukemia (CML) and philadelphia chromosome-positive acute lymphoblastic leukemia (ph + all): Pooled analysis of over 2,400 patients in Indian Journal of Hematology and Blood Transfusion
2014
AOU San Luigi di Orbassano
Bhadauria HS; Saglio G; Le Coutre P; Cortes J; Mayer J; Rowlings P; Subar M; Preston J; Shah N;
BCR-ABL inactivates cytosolic pten through casein kinase II mediated tail phosphorylation in Haematologica
2014
AOU San Luigi di Orbassano
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Pandolfi PP; Saglio G;
ENESTnd 5-year (y) update: Long-term outcomes of patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib (NIL) versus imatinib (IM) in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Larson RA; Kim D-W; Jootar S; Pasquini R; Clark RE; Lobo C; Goldberg SL; Shibayama H; Hochhaus A; Saglio G; Kantarjian HM; Kemp C; Deng W; Menssen HD; Hughes TP;
Treatment-free remission (TFR) following nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Mahon F-X; Baccarani M; Mauro MJ; Hughes TP; Saglio G; Savona M; Szczudlo TK; Menssen HD; Keir CH; Walasek C; Hochhaus A;
Decitabine in advanced chronic myelomonocytic leukemia in Blood
2013
AOU San Luigi di Orbassano
Santini V; Allione B; Levis A; Gioia D; Lunghi M; Poloni A; Cilloni D; Zini G; Sanna A; Rossi A; Terenzi A; Angelucci E; Finelli C; Onida F; Rossi G; Ferrero D; Saglio G; Masiera E;
Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 4-year (y) update in Journal of Clinical Oncology
2013
AOU San Luigi di Orbassano
Larson RA; Hochhaus A; Saglio G; Kim D-W; Jootar S; Le Coutre PD; Reiffers J; Pasquini R; Goldberg SL; Clark RE; Kemp CN; Fan X; Menssen HD; Hughes TP; Kantarjian HM;
Impact of early molecular response to nilotinib (NIL) or imatinib (IM) on the long-term outcomes of newly diagnosed patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): Landmark analysis of 4-year (y) data from ENESTnd in Journal of Clinical Oncology
2013
AOU San Luigi di Orbassano
Saglio G; Hughes TP; Larson RA; Issaragrilsil S; Turkina AG; Steegmann JL; Lopez JL; Nakaseko C; Kalaycio ME; Huguet F; Kemp CN; Fan X; Menssen HD; Kantarjian HM; Hochhaus A;
Chronic myeloid leukemia: state of the art in 2012. in Current oncology reports / Curr Oncol Rep. 2012 Oct;14(5):379-86. doi: 10.1007/s11912-012-0253-9.
2012
AOU San Luigi di Orbassano
Fava C; Rege-Cambrin G; Saglio G;
Single-nucleotide polymorphisms of ABCB1 gene influence intracellular concentrations of Dasatinib in Blood
2012
AOU San Luigi di Orbassano
D'Avolio A; De Francia S; Ariaudo A; Simiele M; Cusato J; Fava C; Baietto L; Di Perri G; Saglio G;
High eutos score is predictive for adverse outcome in early chronic phase CML patients treated with nilotinib-based regimens in Haematologica
2012
AOU San Luigi di Orbassano
Castagnetti F; Gugliotta G; Palandri F; Breccia M; Levato L; Stagno F; Rege Cambrin G; Luciano L; Specchia G; Abruzzese E; Gozzini A; Martino B; Capucci A; Intermesoli T; Tiribelli M; Cedrone M; Cavazzini F; Soverini S; Testoni N; Saglio G; Martinelli G; Pane F; Alimena G; Rosti G; Baccarani M;
Frontline nilotinib 400 mg bid in early chronic phase chronic myeloid leukemia: Stable results beyond 4 years-the gimema CML WP trial CML0307 in Haematologica
2012
AOU San Luigi di Orbassano
Gugliotta G; Castagnetti F; Breccia M; Levato L; Capucci A; Tiribelli M; Zaccaria A; Bocchia M; Cuneo A; Stagno F; Specchia G; Musso M; Martino B; Cedrone M; Intermesoli T; Palandri F; Soverini S; Baldazzi C; Durante S; Testoni N; Alimena G; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G;
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: Three centres experience in Haematologica
2012
AOU San Luigi di Orbassano
Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P;
Nilotinib versus imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd 3-year (yr) follow-up (f/u) in Journal of Clinical Oncology
2012
AOU San Luigi di Orbassano
Kantarjian H; Flinn IW; Goldberg S; Bunworasate U; Zanichelli MA; Nakamae H; Hughes TP; Hochhaus A; Saglio G; Woodman RC; Blakesley RE; Kemp CN; Kalaycio ME; Larson RA;
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. in Journal of chromatographic science / J Chromatogr Sci. 2011 Nov-Dec;49(10):753-7. doi: 10.1093/chrsci/49.10.753.
2011
AOU San Luigi di Orbassano
Pirro E; De Francia S; De Martino F; Fava C; Ulisciani S; Cambrin GR; Racca S; Saglio G; Di Carlo F;
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2011 Apr;47(6):814-8. doi: 10.1016/j.ejca.2010.12.026. Epub 2011 Feb 18.
2011
AOU San Luigi di Orbassano
Guglielmelli T; Bringhen S; Rrodhe S; Gay F; Cavallo F; Berruti A; Montefusco V; Piro E; Benevolo G; Petrucci MT; Caravita T; Offidani M; Corradini P; Boccadoro M; Saglio G; Palumbo A;
Thalidomide after lenalidomide: A possible treatment regimen in relapse refractory multiple myeloma patients in British Journal of Haematology
2011
AOU San Luigi di Orbassano
Guglielmelli T; Petrucci MT; Saglio G; Palumbo A;
Emerging targets for hematological malignancies. in Current opinion in drug discovery & development / Curr Opin Drug Discov Devel. 2010 Sep;13(5):548-58.
2010
AOU San Luigi di Orbassano
Cilloni D; Frassoni F; Saglio G;
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. in The New England journal of medicine / N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5.
2010
AOU San Luigi di Orbassano
Saglio G; Kim DW; Issaragrisil S; le Coutre P; Etienne G; Lobo C; Pasquini R; Clark RE; Hochhaus A; Hughes TP; Gallagher N; Hoenekopp A; Dong M; Haque A; Larson RA; Kantarjian HM;
Emerging drugs for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2010 Jun;15(2):175-84. doi: 10.1517/14728211003621220.
2010
AOU San Luigi di Orbassano
Cilloni D; Messa E; Rotolo A; Saglio G;
Proceedings of the Third Global Workshop on Chronic Myeloid Leukemia. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):443-51. doi: 10.3816/CLML.2010.n.077.
2010
AOU San Luigi di Orbassano
Saglio G; Kantarjian H; Holyoake T; Ranganathan A; Cortés JE;
Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging. in Haematologica / Haematologica. 2010 Aug;95(8):1308-16. doi: 10.3324/haematol.2009.016824. Epub 2010 Jun 9.
2010
AOU San Luigi di Orbassano
Messa E; Carturan S; Maffè C; Pautasso M; Bracco E; Roetto A; Messa F; Arruga F; Defilippi I; Rosso V; Zanone C; Rotolo A; Greco E; Pellegrino RM; Alberti D; Saglio G; Cilloni D;
The best frontline therapy for CML: imatinib? in Clinical advances in hematology & oncology : H&O / Clin Adv Hematol Oncol. 2010 Apr;8(4):240-2.
2010
AOU San Luigi di Orbassano
Saglio G;
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. in International journal of hematology / Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.
2009
AOU San Luigi di Orbassano
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A;
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1721-6. doi: 10.1016/j.jchromb
2009
AOU San Luigi di Orbassano
De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G;
Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia. in Journal of oncology / J Oncol. 2009;2009:867380. doi: 10.1155/2009/867380.
2009
AOU San Luigi di Orbassano
Guglielmelli T; Merlini R; Giugliano E; Saglio G;
2009
AOU San Luigi di Orbassano
Rondoni M; Ottaviani E; Cilloni D; Paolo Piccaluga P; Paolini S; Iacobucci I; Soverini S; Merante S; Messa F; Buccisano F; Tiribelli M; Pane F; Saglio G; Lauria F; Baccarani M; Martinelli G;
Studies on c-KIT protein expression and c-KIT gene mutation in multiple myeloma in Haematologica
2009
AOU San Luigi di Orbassano
Merlini R; Serra A; Giugliano E; Pautasso M; Cappia S; Capotti M; Guglielmelli T; Saglio G;
TFR2 beta isoforms are differentially localized in cells and respond differently to iron treatment in American Journal of Hematology
2009
AOU San Luigi di Orbassano
Pellegrino RM; Defilippi I; Bracco E; Carturan S; Palmieri A; Cilloni D; Saglio G; Roetto A;
2009
AOU San Luigi di Orbassano
Rondoni M; Cilloni D; Paolini S; Ottaviani E; Messa F; Piccaluga PP; Merante S; Buccisano F; Titibelli M; Vigna E; Spadea A; Messa E; Pane F; Saglio G; Lauria F; Baccarani M; Martinelli G;
2009
AOU San Luigi di Orbassano
Castagnetti F; Palandri F; Amabile M; Testoni N; Luatti S; Soverini S; Iacobucci I; Breccia M; Cambrin GR; Stagno F; Specchia G; Galieni P; Iuliano F; Pane F; Saglio G; Alimena G; Martinelli G; Baccarani M; Rosti G;
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
2008
AOU San Luigi di Orbassano
Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A;
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy. in Haematologica / Haematologica. 2008 Jun;93(6):921-4. doi: 10.3324/haematol.12165. Epub 2008 Apr 28.
2008
AOU San Luigi di Orbassano
Cilloni D; Messa F; Arruga F; Defilippi I; Gottardi E; Fava M; Carturan S; Catalano R; Bracco E; Messa E; Nicoli P; Diverio D; Sanz MA; Martinelli G; Lo-Coco F; Saglio G;
Molecular monitoring in patients with chronic myelogenous leukemia. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2008 Apr;3(2):65-71. doi: 10.1007/s11899-008-0011-0.
2008
AOU San Luigi di Orbassano
Saglio G; Ulisciani S; Fava M; Gottardi E; Cilloni D;
A young man with persistent eosinophilia. in Internal and emergency medicine / Intern Emerg Med. 2007 Jun;2(2):107-12. doi: 10.1007/s11739-007-0030-1.
2007
AOU San Luigi di Orbassano
Messa E; Cilloni D; Saglio G;
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR?- positive hypereosinophilic syndrome. Results of a multicenter prospective study in Haematologica
2007
AOU San Luigi di Orbassano
Baccarani M; Cilloni D; Rondoni M; Ottaviani E; Messa F; Merante S; Tiribelli M; Buccisano F; Testoni N; Gottardi E; De Vivo A; Giugliano E; Iacobucci I; Paolini S; Soverini S; Rosti G; Rancati F; Astolfi C; Pane F; Saglio G; Martinelli G;
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2006 Nov;1089:411-23. doi: 10.1196/annals.1386.030.
2006
AOU San Luigi di Orbassano
Cilloni D; Messa E; Messa F; Carturan S; Defilippi I; Arruga F; Rosso V; Catalano R; Bracco E; Nicoli P; Saglio G;
WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias. in Hematology (Amsterdam, Netherlands) / Hematology. 2005;10 Suppl 1:76-8. doi: 10.1080/10245330512331390005.
2005
AOU San Luigi di Orbassano
Saglio G; Carturan S; Grillo S; Capella S; Arruga F; Defilippi I; Rosso V; Rauco M; Marina Liberati A; Cilloni D;
2005
AOU San Luigi di Orbassano
Pilatrino C; Cilloni D; Messa E; Morotti A; Giugliano E; Pautasso M; Familiari U; Cappia S; Pelicci PG; Lo Coco F; Saglio G; Guerrasio A;
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:423-31. doi: 10.1196/annals.1322.050.
2004
AOU San Luigi di Orbassano
Saglio G; Morotti A; Mattioli G; Messa E; Giugliano E; Volpe G; Rege-Cambrin G; Cilloni D;
Myelodysplastic syndromes. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2004 Dec;1028:400-8. doi: 10.1196/annals.1322.048.
2004
AOU San Luigi di Orbassano
Cilloni D; Messa F; Carturan S; Arruga F; Defilippi I; Messa E; Gottardi E; Saglio G;
Abl: the prototype of oncogenic fusion proteins. in Cellular and molecular life sciences : CMLS / Cell Mol Life Sci. 2004 Dec;61(23):2897-911. doi: 10.1007/s00018-004-4271-0.
2004
AOU San Luigi di Orbassano
Saglio G; Cilloni D;
2003
AOU San Luigi di Orbassano
Gorin NC; Labopin M; Rocha V; Arcese W; Beksac M; Gluckman E; Ringden O; Ruutu T; Reiffers J; Bandini G; Falda M; Zikos P; Willemze R; Frassoni F; Abecasis M; Abráhamová J; Afanassiev BV; Aglietta M; Alabdulaaly A; Aleinikova O; Paolo Alessandrino E; Al Shemmari SH; Amadori D; Amadori S; Amos T; Andolina M; Andreesen R; Angelucci E; Anhuf J; et alii...
Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. in Haematologica / Haematologica. 2002 Oct;87(10):1014-20.
2002
AOU San Luigi di Orbassano
Giugliano E; Rege-Cambrin G; Scaravaglio P; Wlodarska I; Emanuel B; Stul M; Serra A; Tonso A; Pini M; Saglio G; Hagemeijer A;
From genes to therapy: the case of Philadelphia chromosome-positive leukemias. in Annals of the New York Academy of Sciences / Ann N Y Acad Sci. 2002 Jun;963:306-12. doi: 10.1111/j.1749-6632.2002.tb04122.x.
2002
AOU San Luigi di Orbassano
Cilloni D; Guerrasio A; Giugliano E; Scaravaglio P; Volpe G; Rege-Cambrin G; Saglio G;
Extranodal Hodgkin lymphoma with renal, splenic and uterine involvement. A case report. in La Radiologia medica / Radiol Med. 2002 Jan-Feb;103(1-2):130-3.
2002
AOU San Luigi di Orbassano
Cataldi A; Sardo P; Ventilii G; Guerrasio A; Pilastrino C; Saglio G; Fava C;
Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation. in Cancer genetics and cytogenetics / Cancer Genet Cytogenet. 2002 Feb;133(1):98-101. doi: 10.1016/s0165-4608(01)00564-7.
2002
AOU San Luigi di Orbassano
Scaravaglio P; Guglielmelli T; Giugliano E; Marmont F; Audisio E; Gallo E; Saglio G; Rege-Cambrin G;
A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p in Hematology Journal
2002
AOU San Luigi di Orbassano
Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Beraldi A; Muzio A; Cornaglia E; Saglio G; Levis A;
Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma. in British journal of haematology / Br J Haematol. 1998 Oct;103(1):143-9. doi: 10.1046/j.1365-2141.1998.00927.x.
1998
AOU San Luigi di Orbassano
Pastore C; Gaidano G; Ghia P; Fassone L; Cilia AM; Gloghini A; Capello D; Buonaiuto D; Gonella S; Roncella S; Carbone A; Saglio G;
Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. in British journal of haematology / Br J Haematol. 1997 May;97(2):460-2. doi: 10.1046/j.1365-2141.1997.312676.x.
1997
AOU San Luigi di Orbassano
Lanza C; Volpe G; Basso G; Gottardi E; Barisone E; Spinelli M; Ricotti E; Cilli V; Perfetto F; Madon E; Saglio G;
BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle. in Leukemia & lymphoma / Leuk Lymphoma. 1997 Jul;26(3-4):281-6. doi: 10.3109/10428199709051777.
1997
AOU San Luigi di Orbassano
Saglio G; Pane F; Martinelli G; Guerrasio A;
Molecular pathways in low grade B-cell lymphoma. in Leukemia & lymphoma / Leuk Lymphoma. 1997 Dec;26 Suppl 1:107-13. doi: 10.3109/10428199709058607.
1997
AOU San Luigi di Orbassano
Gaidano G; Pastore C; Capello D; Cilli V; Saglio G;
Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia. in Genes, chromosomes & cancer / Genes Chromosomes Cancer. 1997 Aug;19(4):250-5.
1997
AOU San Luigi di Orbassano
Gaidano G; Pastore C; Santini V; Nomdedeu J; Gamberi B; Capello D; Vischia F; Resegotti L; Mazza U; Ferrini PR; Lo Coco F; Saglio G;
Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. in British journal of haematology / Br J Haematol. 1995 Nov;91(3):625-9. doi: 10.1111/j.1365-2141.1995.tb05358.x.
1995
AOU San Luigi di Orbassano
Serra A; Gottardi E; Della Ragione F; Saglio G; Iolascon A;
Minimal residual disease detection in human leukemias: biologic and clinical significance. in Acta haematologica Polonica / Acta Haematol Pol. 1995;26(2 Suppl 1):19-24.
1995
AOU San Luigi di Orbassano
Saglio G;